Overview

Adiponectin and Insulin Resistance in Diabetic Nephropathy

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
0
Participant gender:
All
Summary
Plasma adiponectin concentration is inversely associated with renal function. There is little literature on adiponectin levels and regulation by antihypertensive medication with an angiotensin II-receptor blocker (ARB), especially in subjects with type 2 diabetes in different stage of chronic kidney disease (CKD).
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Health Science Center of Xi'an Jiaotong University
Health Science Center of Xi’an Jiaotong University
Collaborator:
Shanghai Jiao Tong University School of Medicine
Treatments:
Angiotensin II
Angiotensin II Type 1 Receptor Blockers
Losartan
Criteria
Inclusion Criteria:

- Type 2 diabetic nephropathy

- CKD at stage 1~4

Exclusion Criteria:

- Type 1 diabetes or nondiabetic renal disease

- An elevated plasma K level.